Your browser doesn't support javascript.
loading
Proton pump inhibitors may enhance the risk of citalopram- and escitalopram-associated sudden cardiac death among patients receiving hemodialysis.
Assimon, Magdalene M; Pun, Patrick H; Al-Khatib, Sana M; Brookhart, M Alan; Gaynes, Bradley N; Winkelmayer, Wolfgang C; Flythe, Jennifer E.
Afiliação
  • Assimon MM; University of North Carolina Kidney Center, Division of Nephrology and Hypertension, Department of Medicine, UNC School of Medicine, Chapel Hill, North Carolina, USA.
  • Pun PH; Division of Nephrology, Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA.
  • Al-Khatib SM; Duke Clinical Research Institute, Durham, North Carolina, USA.
  • Brookhart MA; Duke Clinical Research Institute, Durham, North Carolina, USA.
  • Gaynes BN; Division of Cardiology, Duke University Medical Center, Durham, North Carolina, USA.
  • Winkelmayer WC; Department of Population Health Sciences, Duke University School of Medicine, Durham, North Carolina, USA.
  • Flythe JE; Department of Psychiatry, UNC School of Medicine, Chapel Hill, North Carolina, USA.
Pharmacoepidemiol Drug Saf ; 31(6): 670-679, 2022 06.
Article em En | MEDLINE | ID: mdl-35285107
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Citalopram / Sertralina Idioma: En Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Citalopram / Sertralina Idioma: En Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos